CHECKPOINT CAPITAL L.P.

PrivateCIK: 1977548
Location

SAN FRANCISCO, CA

πŸ“‹ What this filing means

CHECKPOINT CAPITAL L.P. filed this quarterly 13F‑HR report disclosing 8 equity positions with a total reported market value of $214.59M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

8
Positions
$214.59M
Total AUM (reported)
2.87M
Total Shares

Allocation by class

TOTAL AUM$214.59M8 positions
COM$131.92M61.5%
SPONSORED ADR$82.67M38.5%

Portfolio Concentration

Top 381.5%4–1018.5%TOP 10100.0%0%100%
Top 3$174.90M81.5%
4–10$39.70M18.5%

Top 3 weight

81.5%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 2.87M

Sole

Full voting authority

2.87M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole8
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings8
Rows:

ARGENX SE

SOLE
SPONSORED ADR
Shares149.98K
TypeSH
Market value$82.67M
38.52%
Sole
149.98K
Shared
0.00
None
0.00

RHYTHM PHARMACEUTICALS INC

SOLE
COM
Shares1.06M
TypeSH
Market value$66.98M
31.21%
Sole
1.06M
Shared
0.00
None
0.00

CORCEPT THERAPEUTICS INC

SOLE
COM
Shares343.92K
TypeSH
Market value$25.24M
11.76%
Sole
343.92K
Shared
0.00
None
0.00

DISC MEDICINE INC

SOLE
COM
Shares265K
TypeSH
Market value$14.03M
6.54%
Sole
265K
Shared
0.00
None
0.00

REVOLUTION MEDICINES INC

SOLE
COM
Shares280K
TypeSH
Market value$10.30M
4.80%
Sole
280K
Shared
0.00
None
0.00

SEPTERNA INC

SOLE
COM
Shares586.47K
TypeSH
Market value$6.20M
2.89%
Sole
586.47K
Shared
0.00
None
0.00

KYMERA THERAPEUTICS INC

SOLE
COM
Shares106.99K
TypeSH
Market value$4.67M
2.18%
Sole
106.99K
Shared
0.00
None
0.00

PROTAGONIST THERAPEUTICS INC

SOLE
COM
Shares81.31K
TypeSH
Market value$4.49M
2.09%
Sole
81.31K
Shared
0.00
None
0.00
CHECKPOINT CAPITAL L.P. 13F Holdings β€” 8 Positions | Finecho